Eisai Trial Site #4
Eisai Trial Site #4
Kurume, Fukuoka, Japan2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants | Hepatic Impairment | Recruiting | Phase 1 | 2026-09-17 | NCT04271488 | |
| A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor | neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT04078295 |